Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults

Journal of Infectious Diseases - Tập 196 Số 12 - Trang 1749-1753 - 2007
Étienne Sokal1, Karel Hoppenbrouwers2, Corinne Vandermeulen2, Michel Moutschen3, Philippe Léonard3, André Moreels4, Michèle Haumont5, Alex Bollen5, Françoise Smets1, Martine Denis6
1Université Catholique de Louvain, Cliniques Universitaires St-Luc, Brussels
2Department of Youth Health Care, Katholieke Universiteit Leuven, Leuven
3Laboratory of Pathology, University of Liège, Liège
4Vrije Universiteit Brussel, Campus Etterbeek, Brussels
5Henogen, Gosselies, Belgium
6GlaxoSmithKline Biologicals, Rixensart, Belgium

Tóm tắt

Từ khóa


Tài liệu tham khảo

Andersson J, 2000, Herpes, 7, 76

Fleisher G, 1979, J Infect Dis, 139, 553, 10.1093/infdis/139.5.553

10.1056/NEJMc055352

Lopes V, 2003, Herpes, 10, 78

10.1097/00005176-200205000-00004

10.1016/j.bbi.2004.09.001

10.1056/NEJMoa023141

10.1002/ana.20820

10.1016/S0264-410X(98)00248-5

Khanna R, 1999, J Immunol, 162, 3063, 10.4049/jimmunol.162.5.3063

Morgan AJ, 1988, J Gen Virol, 69, 2093, 10.1099/0022-1317-69-8-2093

Gu SY, 1995, Dev Biol Stand, 84, 171

10.1016/j.vaccine.2007.04.008

10.1016/S0166-0934(98)00054-8

10.1086/505400

10.1097/00007890-200003150-00053

Thông tin
Thông tin xuất bản

Journal of Infectious Diseases

Tập 196 Số 12

1749-1753

Thông tin tác giả